The European Pharmaceutical Wholesale Industry: - phagro

The European Pharmaceutical Wholesale Industry
Figure 23: Average Share of Direct, Indirect and Induced Effects in Total Value Added
in AUT, ESP, FR, GER, IT, NL, UK, 2003
37.0%
18.2%
44.8%
Direct effects Indirect effects Induced effects
Source: EUROSTAT, IPF research
Induced effects accounted for 18.2% of total effects on average. Investments
caused by the wholesale industry and its supplying industries in the overall economy
accounted for 1,554 million EUR in 2003.
Table 4: Macroeconomic Effects on Value Added, 2003
Country Direct Effect Indirect Effect Induced Effect Total Effect
AUT 114.49 63.49 50.98 228.95
ESP 416.74 318.57 196.71 932.02
FR 836.38 650.20 371.03 1,857.61
GER 1,155.83 1,038.72 393.19 2,587.74
IT 482.38 352.93 222.97 1,058.28
NL 204.34 175.67 91.16 471.18
UK 623,18 560.04 228.28 1,411.49
5.2 Generating Employment
Source: EUROSTAT 2003, IPF research
In 2003, the activities of the pharmaceutical wholesale industry in Austria, France,
Germany, Italy, the Netherlands, the UK and Spain helped to generate 143,638
jobs in these countries. Again, the number of jobs created reflects the size of the
pharmaceutical wholesale industry in the various countries. Therefore, most jobs
were created in Germany with 39,326 employees, of which 12,952 were directly
employed by pharmaceutical wholesalers, followed by France with 29,757 jobs and
the UK with 23,979 jobs created. All in all, 56,040 people were directly employed
in the pharmaceutical wholesale sector. Further 60,978 jobs were created indirectly
by the industry’s business relations with supplying sectors.
IPF Institute for Pharmaeconomic Research 28